Publication | Open Access
Benefits and risks of interferon therapy for hepatitis B #
232
Citations
48
References
2009
Year
Peginterferon alfa has a place as first-line therapy of hepatitis B in patients who are carefully selected on the basis of pretreatment serum HBV DNA and aminotransferase levels, safety considerations, and viral genotype.
| Year | Citations | |
|---|---|---|
Page 1
Page 1